Proteomics ONLINE Webinar 1: Leveraging a New Era of Protein Structure Prediction to Advance Proteomic-Driven Drug Discovery

As we move into the post-genomic era, the spotlight’s on proteomics to deliver novel advances in drug discovery, and it won’t disappoint…

The boom of high throughput proteomic technologies that allow us to identify and quantify proteins, has expanded our repertoire of biomarkers for disease. Plus, exciting advancements in structural proteomics are helping us to uncover new drug targets and opportunities for intervention.

With all this progress, the future looks bright for proteomic-driven drug discovery as we continue to unlock more of the proteome. And we’re still only at the very tip of the iceberg, with patients yet to reap the rewards at the clinic.

Want to learn more about how advances in structural, clinical, and translational proteomics are supporting the discovery of new protein-targeting drugs? Hear from nine expert speakers in our upcoming webinar series, Proteomics ONLINE.

Register for FREE today to get exclusive access to all three webinars in the series. It takes less than a minute!

Here’s a look at what we’ll cover:

Webinar 1: Leveraging a New Era of Protein Structure Prediction to Advance Proteomic-Driven Drug Discovery

Tuesday 29th November at 3pm GMT/10am EST/7am PST

Join us in webinar one to explore the most recent advances in structural proteomics and how they are supporting drug target discovery.

Expanding Cross-Linking Based Structural Proteomics Towards Pharmacological Applications - Alexander Leitner, Principal Scientist, ETH Zurich

Harnessing Integrative Structural Proteomics to Interrogate Protein Dynamics and Interactions - Antonio Calabrese, Group Lead, University of Leeds